BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 7514109)

  • 1. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans.
    Stamler JS; Loh E; Roddy MA; Currie KE; Creager MA
    Circulation; 1994 May; 89(5):2035-40. PubMed ID: 7514109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans.
    Blitzer ML; Loh E; Roddy MA; Stamler JS; Creager MA
    J Am Coll Cardiol; 1996 Sep; 28(3):591-6. PubMed ID: 8772744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a nitric oxide synthase inhibitor in humans with septic shock.
    Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P
    Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endothelium in the maintenance of low pulmonary vascular tone in normal children.
    Celermajer DS; Dollery C; Burch M; Deanfield JE
    Circulation; 1994 May; 89(5):2041-4. PubMed ID: 8181127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans.
    Cooper CJ; Landzberg MJ; Anderson TJ; Charbonneau F; Creager MA; Ganz P; Selwyn AP
    Circulation; 1996 Jan; 93(2):266-71. PubMed ID: 8548898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative contribution of preload and afterload to the reduction in cardiac output caused by nitric oxide synthase inhibition with L-N(G)-methylarginine hydrochloride 546C88.
    Harrison RW; Thakkar RN; Senzaki H; Ekelund UE; Cho E; Kass DA; Hare JM
    Crit Care Med; 2000 May; 28(5):1263-8. PubMed ID: 10834663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of ability of levcromakalim and sodium nitroprusside to reverse the cardiovascular effects of nitric oxide synthase inhibition in the anaesthetised pig.
    Herity NA; Allen JD; Silke B; Adgey AA
    Cardiovasc Res; 1994 Jun; 28(6):894-900. PubMed ID: 7522965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of nitric oxide synthase modulation on porcine systemic and pulmonary circulation in vivo.
    Dahm P; Thörne J; Zoucas E; Mårtensson L; Myhre E; Blomquist S
    Crit Care Med; 1997 Feb; 25(2):280-5. PubMed ID: 9034265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelium-derived relaxing factor is important in mediating the high output state in chronic severe anemia.
    Anand IS; Chandrashekhar Y; Wander GS; Chawla LS
    J Am Coll Cardiol; 1995 May; 25(6):1402-7. PubMed ID: 7722140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans.
    Haynes WG; Noon JP; Walker BR; Webb DJ
    J Hypertens; 1993 Dec; 11(12):1375-80. PubMed ID: 7510736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide: an important role in the maintenance of systemic and pulmonary vascular tone in man.
    Kiely DG; Lee AF; Struthers AD; Lipworth BJ
    Br J Clin Pharmacol; 1998 Sep; 46(3):263-6. PubMed ID: 9764968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine.
    Frew JD; Paisley K; Martin W
    Br J Pharmacol; 1993 Nov; 110(3):1003-8. PubMed ID: 7507774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NG-monomethyl-L-arginine does not restore loss of hypoxic pulmonary vasoconstriction induced by TNF-alpha.
    Johnson D; Hurst T; Wilson T; Murphy F; Saxema A; To T; Mayers I
    J Appl Physiol (1985); 1993 Aug; 75(2):618-25. PubMed ID: 8226460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of an inhibitor of nitric oxide synthase in human-hand veins.
    Bedarida GV; Kim D; Blaschke TF; Hoffman BB
    Horm Metab Res; 1994 Feb; 26(2):109-12. PubMed ID: 7515369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of alveolar gas conductance by NO in man, as based on studies with NO donors and inhibitors of NO production.
    Guazzi M; Arena R; Vicenzi M; Guazzi MD
    Acta Physiol (Oxf); 2009 Jun; 196(2):267-77. PubMed ID: 19032601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of carbon dioxide on hypoxic pulmonary vasoconstriction in the rat lung: evidence against specific endothelium-derived relaxing factor-mediated vasodilation.
    Baudouin SV; Evans TW
    Crit Care Med; 1993 May; 21(5):740-6. PubMed ID: 8482095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock.
    Klemm P; Thiemermann C; Winklmaier G; Martorana PA; Henning R
    Br J Pharmacol; 1995 Jan; 114(2):363-8. PubMed ID: 7533615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute compensation to abrupt occlusion of rat femoral artery is prevented by NO synthase inhibitors.
    Unthank JL; Nixon JC; Dalsing MC
    Am J Physiol; 1994 Dec; 267(6 Pt 2):H2523-30. PubMed ID: 7529001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation.
    Gilligan DM; Panza JA; Kilcoyne CM; Waclawiw MA; Casino PR; Quyyumi AA
    Circulation; 1994 Dec; 90(6):2853-8. PubMed ID: 7994830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Inhibition of Nitric Oxide Synthase on Muscular Arteries During Exercise: Nitric Oxide Does Not Contribute to Vasodilation During Exercise or in Recovery.
    O'Gallagher K; Shabeeh H; Munir S; Roomi A; Jiang B; Guilcher A; Brett S; Chowienczyk P
    J Am Heart Assoc; 2020 Aug; 9(16):e013849. PubMed ID: 32781940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.